#USA #New York #Securities Fraud #Pomerantz LLP #Geron Corporation

Investor Alert: Investigation of Geron Corporation

The Pomerantz Law Firm is currently conducting an investigation on behalf of investors pertaining to Geron Corporation, known by its NASDAQ ticker symbol GERN. This investigation seeks to unearth potential misconduct by the company and its officers or directors related to securities fraud and other unlawful business activities.

Background of the Investigation

On February 26, 2025, Geron Corporation released its financial outcomes for both the fourth quarter and full year of 2024. In the context of this announcement, company executives conveyed concerns about the performance of their newly approved blood disorder medication, Rytelo. They observed a stagnation in revenue trends, which raised alarms among investors and analysts alike.

In the immediate aftermath of the announcement, the stock price of Geron decreased significantly during trading hours on that day. This drop prompted Pomerantz LLP to take a closer look at the circumstances surrounding the financial report and management's comments.

The law firm advises investors who may have suffered losses to reach out and provide their information. Danielle Peyton, a representative from the firm, is available at the phone number provided for inquiries related to joining this class-action investigation.

About Pomerantz LLP

Pomerantz LLP stands out as a leading law firm in New York, with additional offices in Chicago, Los Angeles, London, Paris, and Tel Aviv. Known for its role in corporate, securities, and antitrust class action litigation, Pomerantz has a distinguished history. Founded by Abraham L. Pomerantz, who is often referred to as the dean of class action law, the firm has spent more than 85 years fighting for victims of corporate misconduct. The firm has a track record of recovering extensive damages on behalf of class members involved in securities fraud and breaches of fiduciary duty.

This investigation into Geron Corporation's business practices represents the firm’s commitment to uphold investor rights and accountability in corporate governance.

For additional details about this specific case, interested parties are encouraged to follow the communication channels provided by Pomerantz LLP. Potential class members may find further information about joining the action through their official website.

The firm emphasizes that past results from similar cases do not guarantee comparable outcomes. However, Pomerantz's longstanding ethical commitment to its clients remains steadfast.

In summary, as Geron's stock experiences volatility following the troubling financial disclosures, affected investors are urged to consider their legal options. With the firm’s rich history of litigation in corporate fraud cases, investors may find solace in joining forces with Pomerantz LLP to seek redress for their financial losses incurred due to potential mismanagement or misconduct within Geron Corporation.